Active not recruitingOBSERVATIONAL

Describing Treatment Patterns and Creating an Updated Treatment Flow in an Ulcerative Colitis Population

This study aims to understand how different treatments for ulcerative colitis (UC) are being used and how effective they are. Researchers are looking back at patient information to see how treatment plans have changed over the years. They want to find out if switching to stronger treatments earlier can help people with UC whose inflammation isn't well controlled. The main goal is to improve our understanding of long-term health for people living with UC and to see how doctors decide which treatments to use. This kind of study helps improve care for everyone with ulcerative colitis.

At a glance

Status

Active not recruiting

Sponsor

Pfizer

Enrolment target

4,000

Start

01 Apr 2026

Estimated completion

31 Jul 2026

Ulcerative Colitis

What is this study about?

This study, called "Describing Treatment Patterns and Creating an Updated Treatment Flow in an Ulcerative Colitis Population," is all about understanding how people with ulcerative colitis (UC) are treated today and how this could be improved. Ulcerative colitis is a long-term condition that causes inflammation in the large intestine. Doctors want to learn more about how treatments are currently used and whether certain approaches lead to better long-term health.

The researchers are particularly interested in what happens when someone's UC isn't well controlled, meaning their symptoms and inflammation continue despite ongoing treatment. They want to investigate if starting more advanced treatments earlier in these situations can make a big difference in controlling inflammation and improving a person's overall health over time. This isn't a study where people receive new medicines; instead, doctors are looking at existing patient records to learn from past experiences.

By carefully looking at lots of patient data, this study hopes to create a clearer picture of the best ways to manage ulcerative colitis. The information gathered will help doctors and healthcare teams understand the "flow" of treatments – meaning, which treatments are used, when they are started, and how effective they are. This knowledge is really important for developing better care plans and helping people with UC live healthier lives.

Key takeaways

This study looks at past medical records, not real-time patient involvement.
It aims to understand how ulcerative colitis treatments have changed and their long-term effects.
Researchers are particularly interested in early use of stronger treatments for hard-to-control UC.
The findings could help doctors make better treatment choices for future patients.
There are no direct risks or personal commitments for patients whose data is used.

Who may be eligible?

To be included in this study, people must have been enrolled in a special registry for bowel conditions (called an IBD registry) since 2009. They also needed to be diagnosed with ulcerative colitis when they were 18 years old or older. The study is looking at information that has already been collected, not new information.

Your medical information would only be included if it was added to the registry during the study's specific time period. Also, there needs to be at least six months of information available about your health after you were diagnosed with ulcerative colitis. This helps researchers understand the long-term effects of treatments.

This study is open to both men and women, and it includes people aged 19 and older. There isn't an upper age limit mentioned, meaning older adults are also included if they meet the other criteria.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

Were you diagnosed with ulcerative colitis when you were 18 or older?
Is your medical information stored in an IBD (Inflammatory Bowel Disease) registry from 2009 or later?
Do your records show at least 6 months of data after your UC diagnosis?
Are you male or female and aged 19 or older?

Answer every question to see your result.

What does participation involve?

This is a "non-interventional study," which means you wouldn't actually "participate" in the way you might imagine with a typical drug trial. You wouldn't attend any extra hospital visits, take any new medications, or have any special tests. Instead, researchers are looking back at information that has already been collected as part of your routine medical care and stored in a special database (an IBD registry). They will simply review this existing data to understand treatment patterns and health outcomes. Therefore, there are no direct actions or commitments required from you if your information is included, and no set duration for your involvement, as they are reviewing historical records.

Potential risks and benefits

Since this study only involves looking at existing, anonymous patient records, there are no direct physical risks to patients. Your personal identity would be protected, and the information used would not be linked back to you personally. The main benefit is that the knowledge gained from studying past treatment patterns can help improve care and treatment decisions for other people with ulcerative colitis in the future. As this is a review of existing data, there's no personal right to withdraw your anonymous, previously collected data, but you always have the right to discuss concerns about how your medical information is used with your doctor.

Locations (1)

Some site locations are approximate. We're improving this — please verify with the trial team before travelling.

Pfizer
Verified postcode
Tadworth, United Kingdom

Common questions

What is ulcerative colitis?

Ulcerative colitis is a type of inflammatory bowel disease (IBD) that causes long-lasting inflammation and sores (ulcers) in the lining of your large intestine (colon and rectum).

Will I have to take new medicine in this study?

No, this is a 'non-interventional' study, which means no new medicines or treatments are given. Researchers are just looking at existing medical records.

Who is running this study?

The information provided doesn't specify the exact organisation or sponsor, but it's a recognised clinical trial looking into ulcerative colitis treatment patterns.

Will my personal details be safe?

Yes, studies like this are designed to protect your privacy. Your personal identity would not be used, and the information is usually anonymised.

Why is this study important?

It's important because it helps doctors understand which treatments work best for ulcerative colitis over time, especially for people whose condition is hard to control. This can lead to better care for everyone.